News from Zyme and the companies we work with.

August 21, 19

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

New offices at leading science hub support the Company’s rapid growth following recent investment New facility is in addition to headquarters at Babraham Research Campus, Cambridgeshire, UK and offices in Monmouth Junction, New Jersey, USA  Cambridge, UK, 21 August 2019: … Continue reading →

August 9, 19

Start Codon partners with Clustermarket and Science Entrepreneur Club to support life science and healthcare start-ups

Clustermarket to provide Start Codon companies with access to cutting edge research equipment and services, Science Entrepreneur Club to offer opportunities to network and showcase innovation Start Codon to co-sponsor Connect2Innovate Meetup on Tuesday 13th August 2019, 18:00-21:00 at The … Continue reading →

August 6, 19

Expedeon AG signs commercial agreement with Sona Nanotech

Agreement will address limitations in development of multiplex point-of-care Lateral Flow Assay diagnostic tests Halifax, Canada, Heidelberg, Germany and Cambridge, UK, 06 August 2019: Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) and Sona Nanotech Inc. (CSE: SONA) (“Sona”), today … Continue reading →

August 5, 19

TTP Labtech introduces chameleon, automated system for next generation cryo-electron microscopy sample-prep

Developed to enable the reliable, consistent and scalable application of cryo-electron microscopy to protein research and drug discovery chameleon to be showcased at Microscopy & Microanalysis 2019 in Portland, Oregon, August 4–8 Cambridge, UK, 05 August 2019: TTP Labtech Ltd, … Continue reading →

August 5, 19

The Native Antigen Company Introduces Rubella Virus-Like Particles

Recombinant expression of Rubella VLPs offers a reliable source of reagents for consistency in immunoassay development and manufacturing The Rubella VLPs are a unique product in The Native Antigen Company’s new Rubella virus product range of antigens, antibodies and ELISAs … Continue reading →

July 29, 19

NemaMetrix raises $5 million USD funding and strengthens senior team

Investment will be used to further develop the Company’s Precisome platform for functional analysis New investment led by Oregon Venture Fund Dr Stephen Turner appointed as Senior Research Fellow to help lead company expansion Eugene, Oregon, USA, 29 July 2019: … Continue reading →

July 29, 19

IONTAS announces new antibody optimisation agreement with Teva Pharmaceuticals

Cambridge, UK, 29 July 2019: IONTAS Limited (IONTAS), a leader in antibody discovery and optimisation of human monoclonal antibody libraries, today announced an agreement with Teva Pharmaceuticals (Teva) to apply its technologies and know-how to the optimisation of human antibodies … Continue reading →

July 24, 19

Arcis Biotechnology appoints Professor Steve Howell as Non-Executive Chairman

Daresbury, UK, 24 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors. Steve takes over the position from Paul Foulger, who … Continue reading →

July 23, 19

Lab of the Future Congress, 13-14th November 2019, Cambridge UK

An international congress bringing together leading pharmaceutical companies, research institutes and service providers to drive collaboration and innovation in the life sciences Cambridge, UK, 23 July 2019: Open Pharma Research, a platform for information exchange and networking in the life … Continue reading →

July 22, 19

BIA Separations selected for manufacturing process development support for gene therapy pipeline

BIA Separations will provide expertise in next generation biomolecule purification processes and long-term supply of CIMmultus™ monolithic columns Initial focus on the manufacture of Zolgensma®, a gene therapy for pediatric patients with spinal muscular atrophy (SMA) less than the age … Continue reading →